Hsp90 and the Fanconi anemia pathway: a molecular link between protein quality control and the DNA damage response.
Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an essential role in cell growth and survival. The chaperone exerts these functions by regulating key signaling proteins involved in cell growth/survival and protecting cells from proteotoxic stress. Importantly, Hsp90 inhibitors including geldanamycin analogues show anti-tumor effects. We recently found that Hsp90 promotes stabilization and nuclear localization of the Fanconi anemia (FA) protein FANCA, which is required for activation of the FA pathway. The FA pathway is a multiprotein biochemical pathway involved in genotoxic signaling, defects in which cause genomic instability, hematopoietic stem cell failure and tumor development. Inhibition of Hsp90 impairs the intracellular homeostasis of FANCA, resulting in disruption of the FA pathway. These findings have important implications for rational cancer chemotherapy using Hsp90 inhibitors. We also discuss the possible functions of Hsp90 in FA pathophysiology and stem cell/cancer biology. Based on our findings and other data, we propose that Hsp90 functions as "a guardian of the genome" through the control of DNA repair proteins.
Yamashita
Takayuki
T
Laboratory of Molecular Genetics, Department of Molecular and Cellular Biology, The Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan. y-taka@showa.gunma-u.ac.jp
Oda
Tsukasa
T
Sekimoto
Takayuki
T
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D004249:DNA Damage / Q000187:drug effects / Q000502:physiology*; D005199:Fanconi Anemia / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D051856:Fanconi Anemia Complementation Group Proteins / Q000235:genetics / Q000378:metabolism*; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*
D000970:Antineoplastic Agents; D051856:Fanconi Anemia Complementation Group Proteins; D018841:HSP90 Heat-Shock Proteins